-
<![CDATA[First U.S. Patient Treated With Alveltamig for Small Cell Lung Cancer ]]>
16 Jan 2026 22:01 GMT
Patients with small cell lung cancer are now being treated with a new experimental immunotherapy in the U.S. after the University of Kentucky Markey Cancer Center became the first site in the country to open a clinical trial of Alveltamig (ZG006), with the …
-
Markey Cancer Center treats 1st patient in U.S. with new lung cancer therapy
15 Jan 2026 15:34 GMT
Markey medical oncologist Zhonglin Hao is leading a clinical trial for ZG006, a more powerful successor to FDA-approved immunotherapy that could help small cell lung cancer patients who’ve run out of options. Photo by Shaun Ring.
LEXINGTON, Ky. — The …
-
Bacterial metabolite enhances immune checkpoint therapy against lung cancer
15 Jan 2026 04:09 GMT
… , when given to mice with lung tumors, boosted their response to immunotherapy … was also funded by the National Cancer Institute, the UF Health Cancer Institute …
-
Targeted Co-Delivery of Curcumin and Astragaloside IV via Hybrid Membrane-Coated Biomimetic Liposomes for Enhanced Lung Cancer Therapy
13 Jan 2026 15:25 GMT
Introduction
Lung cancer is the cancer with the highest incidence and mortality rate in the world, seriously threatening human health and survival.1,2 Clinical treatments for lung cancer mainly include surgery, radiotherapy, immunotherapy and targeted …
-
Simmons Cancer Center Earns Exceptional Rating in Its Renewal as an NCI-Designated Comprehensive Cancer Center
15 Jan 2026 07:48 GMT
Newswise — DALLAS – Jan. 14, 2026 – The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern earned an exemplary merit score from the Center for Scientific Review as part of the renewal of its comprehensive designation by the National Cancer …
-
<![CDATA[Report Finds Seventy Percent 5-Year Survival Rate for All Cancers Combined]]>
16 Jan 2026 20:06 GMT
The American Cancer Society has released its 2026 cancer statistics report, estimating the number of new cancer cases and deaths in the US, with 1 key finding revealing that the most recent 5-year relative survival across all cancers was 70% for diagnoses …
-
Young people hit by deadly cancer at alarming rates... but a new report reveals why there's a glimmer of hope
15 Jan 2026 19:48 GMT
Cancer survival rates have surged over the past decade, yet rates of certain cancers, including breast, prostate, liver, melanoma, anal and pancreatic, continue to rise, especially in young Americans.
A new report by the American Cancer Society offers a …
-
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
15 Jan 2026 01:25 GMT
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presence
Next-generation BTK protein degrader APG-3288 receives IND clearance from the U.S. FDA, propelling expansion of global …
-
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Nasopharyngeal Carcinoma in Non-Endemic Regions: A Single-Arm Phase 2 Clinical Trial
14 Jan 2026 17:09 GMT
… using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version … neoadjuvant therapy and documented per NCI-CTCAE v5.0 criteria. The … –70% reported in hepatocellular and lung cancers treated with camrelizumab,9,13 …
-
You’ve Never Been More Likely to Get Cancer, Survive Cancer, or Be Bankrupted by Cancer
14 Jan 2026 13:27 GMT
We’re living in a curious moment for the status of cancer diagnosis and treatment, within the United States. The overall rate of prevalence for diseases that fall under the wide, wide title of “cancers” is increasing. At the same time, steady improvement …
About
© 1995-2026